Kenneth J. Pienta

Kenneth J. Pienta

Chief Tech/Sci/R&D Officer at James Buchanan Brady Urological Institute

64 year
Consumer Services
Health Technology

Profile

Kenneth J.
Pienta
is currently the Research Director at James Buchanan Brady Urological Institute and a Professor at The Johns Hopkins University.
He previously held positions as the Director-Prostate Specialized Program at the University of Michigan, Director-Experimental Therapeutics at Michigan Center for Translational Pathology, and Independent Director at Curis, Inc. He was also a Director at GreenMark Biomedical, Inc. and is currently the Chief Medical Officer at Cue Biopharma, Inc. Pienta received his undergraduate degree from The Johns Hopkins University and his doctorate from The Johns Hopkins University School of Medicine.

Kenneth J. Pienta active positions

CompaniesPositionStart
James Buchanan Brady Urological Institute Chief Tech/Sci/R&D Officer 2013-02-28
The Johns Hopkins University Corporate Officer/Principal 1993-12-31
All active positions of Kenneth J. Pienta

Former positions of Kenneth J. Pienta

CompaniesPositionEnd
CUE BIOPHARMA, INC. Chief Tech/Sci/R&D Officer 2023-01-16
Director/Board Member 2019-12-31
CURIS, INC. Director/Board Member 2017-04-30
Michigan Center for Translational Pathology Corporate Officer/Principal 2013-01-31
University of Michigan Corporate Officer/Principal -
See the detail of Kenneth J. Pienta's experience

Training of Kenneth J. Pienta

The Johns Hopkins University Undergraduate Degree
The Johns Hopkins University School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kenneth J. Pienta's experience

Connections

100 +

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
CURIS, INC.

Health Technology

CUE BIOPHARMA, INC.

Health Technology

Private companies2
Michigan Center for Translational Pathology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Kenneth J. Pienta